HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Flucloxacillin

HCID 21319
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
5250-39-5
Standard SMILES
Cc1onc(-c2c(F)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O
InChIKey
UIOFUWFRIANQPC-JKIFEVAISA-N
Molecular formula
C19H17ClFN3O5S
Average molar mass
453.9 g/mol
Monoisotopic mass
453.0561477

Overview

Flucloxacillin is a penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of a flucloxacillin(1-).

Names & identifiers

Preferred name
Flucloxacillin
IUPAC
(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
English name
Flucloxacillin
Molecular formula
C19H17ClFN3O5S
Molecular weight
453.87

Names & synonyms

FlucloxacillinFLOXACILLIN5250-39-5flucloxacilinaFlucloxacillineFlucloxacillinumBRL 2039Fluorochloroxacillin3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillinflucloxacillinaBRL-2039(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Show more names
FlopenFlucilCulpenFK 900FlupenPenplusFloxapenStaphylex
ABBOFLOXSTAPHLIPENCHEBI:5098DTXSID802305643B2M34G2V(2S,5R,6R)-6-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S(2alpha,5alpha,6beta))6-(3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid

Database identifiers

Properties

Computed structural propertiesFilling in

XLogP
2.6
Topological polar surface area
138 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
8
Rotatable bonds
4
Heavy atoms
30
Formal charge
0
Complexity
758

Experimental & physicochemical properties

Drugs · 4 items

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals -> Anti infectives for systemic use -> Antibacterials for systemic use

LogP · 2 items

3.2

2.58

Solubility5.45e-02 g/L
Human Drugs · 2 items

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Penicillins

Access group antibiotics

Physical DescriptionSolid

Physicochemical properties

Boiling point
677.3 · 677.3±55.0 °C(Predicted)
Density
1.59 · 1.59±0.1 g/cm3(Predicted)
solubility
soluble in Methanol, Water
pka
2.7 · pKa 2.7 (Uncertain)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Other Safety InformationIMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, [2S-(2.alpha.,5.alpha.,6.beta.)]-: Environment tier I assessment

Toxicology

Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Flucloxacillin

DILI Positive

oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Chemistry & industry

Pharmacology

ATC Code · 5 items

J01CF05

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

J01CF02

Pharmacodynamics · 1 item

Flucloxacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Flucloxacillin has <i>in vitro</i> activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Flucloxacillin results from the inhibition of cell wall synthesis and is mediated through flucloxacillin binding to penicillin binding proteins (PBPs). Flucloxacillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Mechanism of Action · 1 item

By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, flucloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that flucloxacillin interferes with an autolysin inhibitor.

Biological Half-Life0.75–1 hour
Metabolism/Metabolites · 2 items

Hepatic.

Flucloxacillin has known human metabolites that include 6-[[3-(2-Chloro-6-fluorophenyl)-5-(hydroxymethyl)-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and ExcretionBioavailability is 50–70% following oral administration.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CAS
5250-39-5
PubChem CID
21319
DTXSID
DTXSID8023056
ChEMBL
CHEMBL222645
ChEBI
CHEBI:5098
UNII
43B2M34G2V
EC Number
226-051-0
Nikkaji
J8.825K
form
Solid
color
White
CAS DataBase Reference
5250 · 5250-39-5(CAS DataBase Reference)
FDA UNII
43 B2M34G2V · 43B2M34G2V
ATC code
1 CF05 · J01CF05
Protein binding
95 % · 95%
Excreted unchanged in urine
66 · 66-76%
Volume of distribution
0.13 · 0.13
Biological half-life
53 · 53-60 minutes / 135-173 minutes
Cellular LocationsCytoplasm

Uses & manufacturing

UsesUse (kg) in Switzerland (2009): >250
Applications · 3 items

DescriptionChemically this is 3(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl penicillin; this differs from dicloxacillin only by the substitution of a fluorine for a chlorine atom (Sutherland et al., 1970). It comes as oral capsules of 250 and 500 mg, as a suspension of 25 and 50 mg/ml, and in an injectable formulation of 500 mg and 1 g.

UsesAntibacterial.

General DescriptionFlucloxacillin was synthesized by Beecham Research Laboratories in 1962 as a penicillinase-stable and orally active semisynthetic penicillin. It shows almost the same activity as dicloxacillin, and it has slightly higher serum and tissue concentrations than dicloxacillin. This drug has been used to treat pyoderma, sepsis, and postoperative infections as well as ear and nose, respiratory tract, and other infections caused by Staphylococcus and Streptococcus, including benzylpenicillin-resistant strains.

Upstream & downstream products

Upstream raw materials

Thionyl chlorideSodium hydroxideSodium MethoxideMethyl acetoacetateChlorine6-Aminopenicillanic acid2-Chloro-6-fluorobenzaldoxime

Additional notes

DefinitionChEBI: A penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain.